Uncategorized

A collaboration between Institute for In Vitro Sciences (IIVS) and Epithelix has been established to expand access to advanced human-relevant respiratory tissue models within the United States. Through this partnership, IIVS will leverage its logistical experience distributing precision- cut lung slices (PCLS) throughout the country...

As we reflect on the changes and announcements from US and international government agencies this year, we are excited about the opportunities that 2026 will bring. We are deeply grateful to all our contributors, collaborators, clients, and supporters for your continued partnership in advancing science...

We are thrilled to announce that IIVS is now offering the EpiSensA (Epidermal Sensitization Assay) as a GLP-compliant method in our sensitization testing portfolio. EpiSensA offers a reliable, human-relevant method for assessing skin sensitization potential, increasing our ability to provide New Approach Methodology (NAM) testing...

Leiden, The Netherlands and Gaithersburg, MD, USA — 17 July 2026 — Toxys and the Institute for In Vitro Sciences (IIVS) are pleased to announce an expanded strategic partnership aimed at accelerating the adoption of innovative in vitro methods for chemical safety assessment. Under a...

IIVS and the Physicians Committee for Responsible Medicine co-organized a webinar series featuring Spanish-speaking experts on ocular irritation, three-dimensional models, and dermal sensitisation. Métodos alternativos en toxicidad ocular: avances, aplicaciones y aceptación regulatoria en Latinoamérica 10 April 2025 Dra. María Laura Gutiérrez Cultivos celulares 2D y 3D en el...

Allergic contact dermatitis (ACD) is an immunologic reaction to a dermal chemical ex-posure that, once triggered in an individual, will result in an allergic response following subsequent encounters with the allergen. Air Force epidemiological consultations have in-dicated that aircraft structural maintenance workers may experience ACD...

Our Respiratory Toxicology team has had a productive year, staying at the forefront of the latest industry developments while also contributing new insights of our own. We've had the opportunity to attend and present at key conferences, as well as showcase the exciting progress we're making in advancing in vitro toxicology testing.

If you will be at EUROTOX, September 8-11, stop by BOOTH #34 to speak with IIVS President, Amanda Ulrey and meet our new Client Relationship Manager Joseph Hughes. We have some new methods available for GLP use now and several others that are currently in the technology transfer phase. We look forward to catching up with you there.